Literature DB >> 15919910

Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients.

Jon M Jacobs1, Deborah L Diamond, Eric Y Chan, Marina A Gritsenko, Weijun Qian, Miroslava Stastna, Tracey Baas, David G Camp, Robert L Carithers, Richard D Smith, Michael G Katze.   

Abstract

The development of a reproducible model system for the study of hepatitis C virus (HCV) infection has the potential to significantly enhance the study of virus-host interactions and provide future direction for modeling the pathogenesis of HCV. While there are studies describing global gene expression changes associated with HCV infection, changes in the proteome have not been characterized. We report the first large-scale proteome analysis of the highly permissive Huh-7.5 cell line containing a full-length HCV replicon. We detected >4,200 proteins in this cell line, including HCV replicon proteins, using multidimensional liquid chromatographic (LC) separations coupled to mass spectrometry. Consistent with the literature, a comparison of HCV replicon-positive and -negative Huh-7.5 cells identified expression changes of proteins involved in lipid metabolism. We extended these analyses to liver biopsy material from HCV-infected patients where a total of >1,500 proteins were detected from only 2 mug of liver biopsy protein digest using the Huh-7.5 protein database and the accurate mass and time tag strategy. These findings demonstrate the utility of multidimensional proteome analysis of the HCV replicon model system for assisting in the determination of proteins/pathways affected by HCV infection. Our ability to extend these analyses to the highly complex proteome of small liver biopsies with limiting protein yields offers the unique opportunity to begin evaluating the clinical significance of protein expression changes associated with HCV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919910      PMCID: PMC1143647          DOI: 10.1128/JVI.79.12.7558-7569.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity.

Authors:  Aparna Venkatraman; Aimee Landar; Ashley J Davis; Laura Chamlee; Todd Sanderson; Helen Kim; Grier Page; Melissa Pompilius; Scott Ballinger; Victor Darley-Usmar; Shannon M Bailey
Journal:  J Biol Chem       Date:  2004-03-18       Impact factor: 5.157

2.  Multidimensional proteome analysis of human mammary epithelial cells.

Authors:  Jon M Jacobs; Heather M Mottaz; Li-Rong Yu; David J Anderson; Ronald J Moore; Wan-Nan U Chen; Kenneth J Auberry; Eric F Strittmatter; Matthew E Monroe; Brian D Thrall; David G Camp; Richard D Smith
Journal:  J Proteome Res       Date:  2004 Jan-Feb       Impact factor: 4.466

3.  Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

Authors:  W Khovidhunkit; R A Memon; J K Shigenaga; M Pang; M Schambelan; K Mulligan; K R Feingold; C Grunfeld
Journal:  Metabolism       Date:  1999-12       Impact factor: 8.694

4.  Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity.

Authors:  Takeya Tsutsumi; Tetsuro Suzuki; Takashi Shimoike; Ryosuke Suzuki; Kyoji Moriya; Yoshizumi Shintani; Hajime Fujie; Yoshiharu Matsuura; Kazuhiko Koike; Tatsuo Miyamura
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

5.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

6.  NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.

Authors:  S L Tan; H Nakao; Y He; S Vijaysri; P Neddermann; B L Jacobs; B J Mayer; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

7.  Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system.

Authors:  Anne G Bost; Daryl Venable; Lifei Liu; Beverly A Heinz
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.

Authors:  Maria W Smith; Zhaoxia N Yue; Marcus J Korth; Hao A Do; Loreto Boix; Nelson Fausto; Jordi Bruix; Robert L Carithers; Michael G Katze
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

9.  Interaction of hepatitis C virus NS5A with La protein revealed by T7 phage display.

Authors:  Hamid Houshmand; Anders Bergqvist
Journal:  Biochem Biophys Res Commun       Date:  2003-09-26       Impact factor: 3.575

10.  Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein.

Authors:  Gary K Geiss; Victoria S Carter; Yupeng He; Bartlomiej K Kwieciszewski; Ted Holzman; Marcus J Korth; Catherine A Lazaro; Nelson Fausto; Roger E Bumgarner; Michael G Katze
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  38 in total

1.  Extracellular matrix bioengineering and systems biology approaches in liver disease.

Authors:  Natalia Nieto; Matthias P Lutolf
Journal:  Syst Synth Biol       Date:  2011-06-17

2.  Predicting the probable outcome of treatment in HCV patients.

Authors:  Udayakumar Navaneethan; Nyingi Kemmer; Guy W Neff
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

Review 3.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

Review 4.  Advances in proteomics data analysis and display using an accurate mass and time tag approach.

Authors:  Jennifer S D Zimmer; Matthew E Monroe; Wei-Jun Qian; Richard D Smith
Journal:  Mass Spectrom Rev       Date:  2006 May-Jun       Impact factor: 10.946

Review 5.  Viral proteomics.

Authors:  Karen L Maxwell; Lori Frappier
Journal:  Microbiol Mol Biol Rev       Date:  2007-06       Impact factor: 11.056

Review 6.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

7.  Hepatitis C virus host cell interactions uncovered.

Authors:  Judith M Gottwein; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-07       Impact factor: 11.205

8.  Optimization of proteomic sample preparation procedures for comprehensive protein characterization of pathogenic systems.

Authors:  Heather M Mottaz-Brewer; Angela D Norbeck; Joshua N Adkins; Nathan P Manes; Charles Ansong; Liang Shi; Yasuko Rikihisa; Takane Kikuchi; Scott W Wong; Ryan D Estep; Fred Heffron; Ljiljana Pasa-Tolic; Richard D Smith
Journal:  J Biomol Tech       Date:  2008-12

9.  Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe.

Authors:  Ragunath Singaravelu; David R Blais; Craig S McKay; John Paul Pezacki
Journal:  Proteome Sci       Date:  2010-02-04       Impact factor: 2.480

10.  Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics.

Authors:  Deborah L Diamond; Andrew J Syder; Jon M Jacobs; Christina M Sorensen; Kathie-Anne Walters; Sean C Proll; Jason E McDermott; Marina A Gritsenko; Qibin Zhang; Rui Zhao; Thomas O Metz; David G Camp; Katrina M Waters; Richard D Smith; Charles M Rice; Michael G Katze
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.